SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-03-08 12:07
Tx date 2024-03-06 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+15,688 vol 		101,115
Filed 2024-03-08 12:06
Tx date 2024-03-06 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+9,136 vol 		85,427
Filed 2024-03-08 12:05
Tx date 2024-03-06 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights 		$-200,110.40
-35,734 vol
$5.60 each 		92,284
Filed 2024-03-08 12:00
Tx date 2024-03-06 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights 		$-116,569.60
-20,816 vol
$5.60 each 		128,018
Filed 2023-03-07 10:52
Tx date 2023-03-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+20,816 vol 		76,291
Filed 2023-03-07 10:50
Tx date 2023-03-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
-20,816 vol 		148,834
Filed 2023-03-07 10:49
Tx date 2023-03-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights
+107,202 vol 		169,650
Filed 2022-11-09 16:14
Tx date 2022-11-07 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$154,800
+30,000 vol
$5.16 each 		55,475
Filed 2022-03-07 22:11
Tx date 2022-03-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
57 - Exercise of rights 		$-102,085
-8,500 vol
$12.01 each 		0
Filed 2022-03-07 17:22
Tx date 2022-03-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+3,651 vol 		25,475
Filed 2022-03-07 17:20
Tx date 2022-03-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
57 - Exercise of rights 		$-102,085
-8,500 vol
$12.01 each
Filed 2022-03-07 17:20
Tx date 2022-03-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
57 - Exercise of rights 		$-102,085
-8,500 vol
$12.01 each 		0
Filed 2022-03-07 17:18
Tx date 2022-03-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
58 - Expiration of rights
-34,000 vol 		8,500
Filed 2022-03-07 15:13
Tx date 2022-03-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights
+62,448 vol 		62,448
Filed 2022-03-07 15:12
Tx date 2013-09-14 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 11:07
Tx date 2022-03-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,283,124
+106,838 vol
$12.01 each 		217,363
Filed 2021-11-12 16:37
Tx date 2021-11-11 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-324,500
-11,000 vol
$29.50 each 		21,824
Filed 2021-11-12 16:36
Tx date 2021-11-11 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-835,780
-29,000 vol
$28.82 each 		32,824
Filed 2021-11-12 16:35
Tx date 2021-11-11 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$835,780
+29,000 vol
$28.82 each 		61,824
Filed 2021-11-12 16:33
Tx date 2021-11-11 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-702,380
-29,000 vol
$24.22 each 		110,525
Filed 2021-11-12 16:31
Tx date 2021-11-10 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-305,500
-10,000 vol
$30.55 each 		32,824
Filed 2021-11-12 16:30
Tx date 2021-11-10 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,527,500
-50,000 vol
$30.55 each 		42,824
Filed 2021-11-12 16:29
Tx date 2021-11-09 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,508,500
-50,000 vol
$30.17 each 		92,824
Filed 2021-11-04 09:54
Tx date 2021-11-01 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,423,800
-45,000 vol
$31.64 each 		142,824
Filed 2021-11-04 09:53
Tx date 2021-11-01 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$144,000
+45,000 vol
$3.20 each 		187,824
Filed 2021-11-04 09:45
Tx date 2021-11-01 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-189,450
-45,000 vol
$4.21 each 		139,525
Filed 2021-09-23 15:12
Tx date 2021-09-21 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,101,750
-87,500 vol
$24.02 each 		142,824
Filed 2021-09-23 15:10
Tx date 2021-09-21 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$183,800
+10,000 vol
$18.38 each 		230,324
Filed 2021-09-23 15:09
Tx date 2021-09-21 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$424,200
+70,000 vol
$6.06 each 		220,324
Filed 2021-09-23 15:09
Tx date 2021-09-21 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$39,750
+7,500 vol
$5.30 each 		150,324
Filed 2021-09-23 15:08
Tx date 2021-09-20 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-345,600
-16,000 vol
$21.60 each 		142,824
Filed 2021-09-23 15:07
Tx date 2021-09-20 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-271,375
-12,500 vol
$21.71 each 		158,824
Filed 2021-09-23 15:05
Tx date 2021-09-20 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$151,050
+28,500 vol
$5.30 each 		171,324
Filed 2021-09-23 15:03
Tx date 2021-09-21 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-242,200
-10,000 vol
$24.22 each 		184,525
Filed 2021-09-23 15:01
Tx date 2021-09-21 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-562,800
-70,000 vol
$8.04 each 		194,525
Filed 2021-09-23 14:58
Tx date 2021-09-21 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-48,900
-7,500 vol
$6.52 each 		264,525
Filed 2021-09-23 14:56
Tx date 2021-09-20 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-185,820
-28,500 vol
$6.52 each 		272,025
Filed 2021-09-17 15:48
Tx date 2021-09-14 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-159,300
-30,000 vol
$5.31 each 		142,824
Filed 2021-09-17 15:47
Tx date 2021-09-14 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-304,220
-14,000 vol
$21.73 each 		172,824
Filed 2021-09-17 15:45
Tx date 2021-09-14 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$233,639
+44,000 vol
$5.31 each 		186,824
Filed 2021-09-17 15:44
Tx date 2021-09-14 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-286,880
-44,000 vol
$6.52 each 		300,525
Filed 2021-09-17 15:39
Tx date 2021-09-14 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-144,000
-45,000 vol
$3.20 each 		142,824
Filed 2021-09-17 15:38
Tx date 2021-09-14 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$144,000
+45,000 vol
$3.20 each 		187,824
Filed 2021-09-17 15:37
Tx date 2021-09-14 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-189,450
-45,000 vol
$4.21 each 		344,525
Filed 2021-09-17 15:34
Tx date 2021-09-14 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-238,950
-45,000 vol
$5.31 each 		142,824
Filed 2021-09-17 15:33
Tx date 2021-09-14 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$238,949
+45,000 vol
$5.31 each 		187,824
Filed 2021-09-17 15:30
Tx date 2021-09-14 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-293,400
-45,000 vol
$6.52 each 		389,525
Filed 2021-09-17 15:24
Tx date 2021-09-13 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-132,750
-25,000 vol
$5.31 each 		142,824
Filed 2021-09-17 15:22
Tx date 2021-09-13 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$132,750
+25,000 vol
$5.31 each 		167,824
Filed 2021-09-17 15:18
Tx date 2021-09-13 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-163,000
-25,000 vol
$6.52 each 		434,525
Filed 2021-09-08 15:37
Tx date 2021-09-07 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-135,750
-7,500 vol
$18.10 each 		142,824
Filed 2021-08-27 16:21
Tx date 2021-08-26 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-400,725
-22,500 vol
$17.81 each 		150,324
Filed 2021-08-10 16:17
Tx date 2021-08-09 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-80,050
-5,000 vol
$16.01 each 		172,824
Filed 2021-07-29 16:27
Tx date 2021-07-28 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-87,073
-5,000 vol
$17.41 each 		177,824
Filed 2021-06-23 16:37
Tx date 2021-06-22 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-85,050
-5,000 vol
$17.01 each 		182,824
Filed 2021-05-12 17:18
Tx date 2021-05-11 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$78,200
+20,000 vol
$3.91 each 		187,824
Filed 2021-05-12 17:18
Tx date 2021-05-11 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-78,200
-20,000 vol
$3.91 each 		459,525
Filed 2020-12-31 14:37
Tx date 2019-01-11 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-82,450
-19,400 vol
$4.25 each 		368,039
Filed 2020-12-31 14:36
Tx date 2019-01-09 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-170,000
-40,000 vol
$4.25 each 		387,439
Filed 2020-12-31 14:27
Tx date 2019-12-12 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-92,909.25
-21,861 vol
$4.25 each 		330,000
Filed 2020-12-31 14:26
Tx date 2019-09-27 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-78,200
-20,000 vol
$3.91 each 		351,861
Filed 2020-12-31 14:25
Tx date 2019-09-27 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-145,000
-20,000 vol
$7.25 each
Filed 2020-12-31 14:25
Tx date 2019-09-26 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-117,180
-21,000 vol
$5.58 each
Filed 2020-12-31 14:24
Tx date 2019-09-26 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-89,250
-21,000 vol
$4.25 each 		371,861
Filed 2020-12-31 14:22
Tx date 2019-04-26 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-192,006.50
-45,178 vol
$4.25 each 		392,861
Filed 2019-12-17 10:19
Tx date 2019-12-12 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$92,909
+21,861 vol
$4.25 each
Filed 2019-10-01 14:07
Tx date 2019-09-27 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-145,000
-20,000 vol
$7.25 each
Filed 2019-10-01 14:02
Tx date 2019-09-26 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-117,180
-21,000 vol
$5.58 each
Filed 2019-10-01 14:00
Tx date 2019-09-27 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$78,200
+20,000 vol
$3.91 each
Filed 2019-10-01 13:58
Tx date 2019-09-26 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$89,250
+21,000 vol
$4.25 each
Filed 2019-05-02 15:50
Tx date 2019-04-26 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$192,006
+45,178 vol
$4.25 each
Filed 2020-12-28 14:28
Tx date 2020-12-21 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,076,603
+82,625 vol
$13.03 each 		714,003
Filed 2020-12-28 14:19
Tx date 2020-10-23 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
56 - Grant of rights
+42,500 vol 		42,500
Filed 2020-12-28 14:18
Tx date 2013-09-14 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
Filed 2020-02-05 14:53
Tx date 2020-01-28 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,620,318
+66,900 vol
$24.22 each 		631,378
Filed 2019-12-17 10:24
Tx date 2019-12-12 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+20,000 vol 		167,824
Filed 2019-12-17 10:23
Tx date 2019-12-12 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
+20,000 vol
Filed 2019-12-17 10:21
Tx date 2019-12-12 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
+20,000 vol
Filed 2019-12-17 10:19
Tx date 2019-12-12 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$92,909
+21,861 vol
$4.25 each 		564,478
Filed 2019-10-17 12:18
Tx date 2019-10-11 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership
-196,200 vol 		147,824
Filed 2019-10-10 23:42
Tx date 2019-10-10 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$21,204
+3,800 vol
$5.58 each 		344,024
Filed 2019-10-01 14:07
Tx date 2019-09-27 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-145,000
-20,000 vol
$7.25 each 		542,617
Filed 2019-10-01 14:02
Tx date 2019-09-26 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-117,180
-21,000 vol
$5.58 each 		542,617
Filed 2019-10-01 14:00
Tx date 2019-09-27 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$78,200
+20,000 vol
$3.91 each 		562,617
Filed 2019-10-01 13:58
Tx date 2019-09-26 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$89,250
+21,000 vol
$4.25 each 		563,617
Filed 2019-05-02 15:59
Tx date 2018-12-18 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-3,499 vol 		435,200
Filed 2019-05-02 15:58
Tx date 2018-12-13 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$7,498
+3,499 vol
$2.14 each
Filed 2019-05-02 15:54
Tx date 2019-04-26 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-45,178 vol 		340,224
Filed 2019-05-02 15:50
Tx date 2019-04-26 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$192,006
+45,178 vol
$4.25 each 		542,617
Filed 2018-12-13 19:37
Tx date 2018-12-13 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$7,498
+3,499 vol
$2.14 each
Filed 2019-02-01
Tx date 2019-02-01 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$562,799
+70,000 vol
$8.04 each 		497,439
Filed 2019-01-11
Tx date 2019-01-09 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-164,952
-17,400 vol
$9.48 each 		388,901
Filed 2019-01-11
Tx date 2019-01-10 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-19,720
-2,000 vol
$9.86 each 		388,901
Filed 2019-01-11
Tx date 2019-01-10 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$8,500
+2,000 vol
$4.25 each 		390,901
Filed 2019-01-11
Tx date 2019-01-09 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-72,200
-7,600 vol
$9.50 each 		388,901
Filed 2019-01-11
Tx date 2019-01-07 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-379,200
-40,000 vol
$9.48 each 		396,501
Filed 2019-01-11
Tx date 2019-01-07 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$170,000
+40,000 vol
$4.25 each 		436,501
Filed 2019-01-11
Tx date 2019-01-07 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-162,177.14
-17,198 vol
$9.43 each 		396,501
Filed 2019-01-11
Tx date 2019-01-09 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$73,950
+17,400 vol
$4.25 each 		406,301
Filed 2019-01-07
Tx date 2019-01-02 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-233,000
-25,000 vol
$9.32 each 		413,699
Filed 2018-12-13
Tx date 2018-12-13 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$-7,498.357
-3,499 vol
$2.14 each 		1
Filed 2018-12-13
Tx date 2018-12-13 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$7,498
+3,499 vol
$2.14 each 		3,500
Filed 2018-02-03
Tx date 2018-02-01 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$977,999
+150,000 vol
$6.52 each 		427,439
Filed 2017-06-23
Tx date 2017-06-23 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-315,645.8844
-36,762 vol
$8.59 each 		438,699
Filed 2017-06-23
Tx date 2017-06-21 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,015,363.7072
-117,188 vol
$8.66 each 		508,311
Filed 2017-06-23
Tx date 2017-06-22 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-283,012.605
-32,850 vol
$8.62 each 		475,461
Filed 2017-06-23
Tx date 2017-06-21 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-117,647.64
-13,200 vol
$8.91 each 		625,499
Filed 2017-02-13
Tx date 2017-02-09 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$378,900
+90,000 vol
$4.21 each 		277,439
Filed 2016-03-31
Tx date 2016-03-30 		$AUPH
Aurinia Pharmaceuticals Inc. 		Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$156,400
+40,000 vol
$3.91 each 		187,439